<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 15 Jun 2026 08:00:41 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences names Eric Jordan VP of marketing, Tina Gullotta VP of finance</title>
   <link>http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</link>
   <description>

&lt;p&gt;Spruce Biosciences Inc. (NASDAQ: SPRB) announced the appointment of Eric Jordan as vice president of marketing and Tina Gullotta as vice president of finance and corporate controller.&lt;/p&gt;

&lt;p&gt;Jordan brings over 20 years of pharmaceutical and biotech marketing experience. He previously served as marketing team lead at BridgeBio and as vice president of marketing at Dompé Pharmaceuticals, where he led the U.S. launch of Oxervate for neurotrophic keratitis. Jordan also held marketing positions at Aimmune Therapeutics, ZS Pharma, and Genentech.&lt;/p&gt;

&lt;p&gt;Gullotta has more than 25 years of senior finance experience in life sciences. She most recently served as vice president of finance at</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Spruce+Biosciences+names+Eric+Jordan+VP+of+marketing%2C+Tina+Gullotta+VP+of+finance/26644433.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:41 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller</title>
   <link>http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Appointments Further Strengthen Spruce’s Commercial and Financial Capabilities as the Company Approaches a Potential U.S. FDA Approval and Commercial Launch of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Eric Jordan as Vice President, Marketing and Tina Gullotta, CPA, as Vice President, Finance and Corporate Controller.&lt;/p&gt;&lt;p&gt;“We are delighted to welcome both Eric and Tina,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller</title>
   <link>http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Appointments Further Strengthen Spruce’s Commercial and Financial Capabilities as the Company Approaches a Potential U.S. FDA Approval and Commercial Launch of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Eric Jordan as Vice President, Marketing and Tina Gullotta, CPA, as Vice President, Finance and Corporate Controller.&lt;/p&gt;&lt;p&gt;“We are delighted to welcome both Eric and Tina,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller</title>
   <link>http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Appointments Further Strengthen Spruce’s Commercial and Financial Capabilities as the Company Approaches a Potential U.S. FDA Approval and Commercial Launch of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Eric Jordan as Vice President, Marketing and Tina Gullotta, CPA, as Vice President, Finance and Corporate Controller.&lt;/p&gt;&lt;p&gt;“We are delighted to welcome both Eric and Tina,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller</title>
   <link>http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Appointments Further Strengthen Spruce’s Commercial and Financial Capabilities as the Company Approaches a Potential U.S. FDA Approval and Commercial Launch of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Eric Jordan as Vice President, Marketing and Tina Gullotta, CPA, as Vice President, Finance and Corporate Controller.&lt;/p&gt;&lt;p&gt;“We are delighted to welcome both Eric and Tina,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller</title>
   <link>http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Appointments Further Strengthen Spruce’s Commercial and Financial Capabilities as the Company Approaches a Potential U.S. FDA Approval and Commercial Launch of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Eric Jordan as Vice President, Marketing and Tina Gullotta, CPA, as Vice President, Finance and Corporate Controller.&lt;/p&gt;&lt;p&gt;“We are delighted to welcome both Eric and Tina,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller</title>
   <link>http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Appointments Further Strengthen Spruce’s Commercial and Financial Capabilities as the Company Approaches a Potential U.S. FDA Approval and Commercial Launch of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Eric Jordan as Vice President, Marketing and Tina Gullotta, CPA, as Vice President, Finance and Corporate Controller.&lt;/p&gt;&lt;p&gt;“We are delighted to welcome both Eric and Tina,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller</title>
   <link>http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Appointments Further Strengthen Spruce’s Commercial and Financial Capabilities as the Company Approaches a Potential U.S. FDA Approval and Commercial Launch of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Eric Jordan as Vice President, Marketing and Tina Gullotta, CPA, as Vice President, Finance and Corporate Controller.&lt;/p&gt;&lt;p&gt;“We are delighted to welcome both Eric and Tina,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller</title>
   <link>http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Appointments Further Strengthen Spruce’s Commercial and Financial Capabilities as the Company Approaches a Potential U.S. FDA Approval and Commercial Launch of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Eric Jordan as Vice President, Marketing and Tina Gullotta, CPA, as Vice President, Finance and Corporate Controller.&lt;/p&gt;&lt;p&gt;“We are delighted to welcome both Eric and Tina,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
  <item>
   <title>Spruce Biosciences Appoints Eric Jordan as Vice President, Marketing and Tina Gullotta as Vice President, Finance and Corporate Controller</title>
   <link>http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</link>
   <description>
&lt;p class=&quot;bwalignc&quot;&gt;&lt;i&gt;Appointments Further Strengthen Spruce’s Commercial and Financial Capabilities as the Company Approaches a Potential U.S. FDA Approval and Commercial Launch of Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB)&lt;/i&gt;&lt;/p&gt;
&lt;p&gt;    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Eric Jordan as Vice President, Marketing and Tina Gullotta, CPA, as Vice President, Finance and Corporate Controller.&lt;/p&gt;&lt;p&gt;“We are delighted to welcome both Eric and Tina,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Spruce+Biosciences+Appoints+Eric+Jordan+as+Vice+President%2C+Marketing+and+Tina+Gullotta+as+Vice+President%2C+Finance+and+Corporate+Controller/26644399.html</guid>
   <pubDate>Mon, 15 Jun 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06370783</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.14610943</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.24873657</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40151759</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50113906</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213494</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50213522</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00050368</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02206997</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13746533</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20588719</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.25176490</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.37894223</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39469395</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53486143</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SPRB</category>
   	  </item>
 </channel>
</rss>
